Profile data is unavailable for this security.
About the company
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
- Revenue in USD (TTM)0.00
- Net income in USD-6.36m
- Incorporated2013
- Employees3.00
- LocationGalmed Pharmaceuticals Ltd16 Tiomkin StreetTEL AVIV-YAFO 6578317IsraelISR
- Phone+972 36938448
- Fax+972 36938447
- Websitehttps://www.galmedpharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CNS Pharmaceuticals Inc | 0.00 | -17.46m | 1.76m | 3.00 | -- | -- | -- | -- | -179.17 | -179.17 | 0.00 | -20.76 | 0.00 | -- | -- | 0.00 | -384.86 | -132.47 | -- | -185.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -23.42 | -- | -- | -- |
Hi-Great Group Holding Co | 101.27k | -113.56k | 1.78m | -- | -- | -- | -- | 17.58 | -0.0011 | -0.0011 | 0.001 | -0.0011 | 0.7887 | 0.8027 | -- | -- | -88.44 | -- | -- | -- | 48.60 | -- | -112.14 | -- | 0.0197 | -48.81 | -- | -- | -47.32 | -- | -3,789.70 | -- | -- | -- |
Panbela Therapeutics Inc | 0.00 | -27.26m | 1.78m | 7.00 | -- | -- | -- | -- | -20.38 | -20.38 | 0.00 | -0.6563 | 0.00 | -- | -- | 0.00 | -201.94 | -215.89 | -809.38 | -476.38 | -- | -- | -- | -- | -- | -161.79 | 4.16 | -- | -- | -- | 27.68 | -- | -- | -- |
Windtree Therapeutics Inc | 0.00 | -5.96m | 1.88m | 15.00 | 0.1716 | 0.1052 | -- | -- | 18.53 | 18.53 | 0.00 | 30.23 | 0.00 | -- | -- | 0.00 | -18.26 | -44.51 | -20.72 | -48.38 | -- | -- | -- | -94,533.34 | -- | -- | 0.00 | -- | -- | -- | 48.25 | -- | -- | -- |
PaxMedica Inc | 0.00 | -18.15m | 1.94m | 6.00 | -- | 1.57 | -- | -- | -11.19 | -11.19 | 0.00 | 0.1594 | 0.00 | -- | -- | 0.00 | -474.77 | -755.77 | -781.78 | -- | -- | -- | -- | -- | -- | -3,015.03 | 0.00 | -- | -- | -- | -23.56 | -- | -- | -- |
Galmed Pharmaceuticals Ltd | 0.00 | -6.36m | 1.97m | 3.00 | -- | 0.1462 | -- | -- | -2.83 | -2.83 | 0.00 | 2.12 | 0.00 | -- | -- | 0.00 | -43.37 | -45.06 | -51.38 | -50.79 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.31 | -- | -- | -- |
Finch Therapeutics Group Inc | 0.00 | -16.28m | 2.04m | 18.00 | -- | 0.1071 | -- | -- | -10.14 | -10.14 | 0.00 | 11.86 | 0.00 | -- | -- | -- | -25.22 | -- | -28.97 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -87.57 | -- | 34.80 | -- | -- | -- |
Soligenix Inc | 699.21k | -7.01m | 2.08m | 13.00 | -- | 1.81 | -- | 2.98 | -11.83 | -11.83 | 1.16 | 1.17 | 0.073 | -- | 4.17 | 53,785.38 | -73.17 | -75.40 | -2,448.34 | -154.32 | 9.46 | 22.83 | -1,002.55 | -620.02 | -- | -- | 0.7959 | -- | -11.54 | -30.67 | 55.50 | -- | -- | -- |
VG Life Sciences Inc | 0.00 | -4.30m | 2.11m | 7.00 | -- | -- | -- | -- | -0.0721 | -0.0721 | 0.00 | -0.0491 | 0.00 | -- | -- | -- | -384.41 | -294.08 | -- | -- | -- | -- | -- | -587,591.90 | -- | -1.70 | -- | -- | -- | -- | 16.58 | -- | -- | -- |
Azitra Inc | 572.70k | -12.40m | 2.18m | 10.00 | -- | 0.504 | -- | 3.81 | -86.11 | -86.11 | 1.48 | 4.50 | 0.0977 | -- | 11.54 | 57,270.00 | -200.61 | -- | -287.43 | -- | -- | -- | -2,053.34 | -- | -- | -129.02 | 0.0085 | -- | 141.55 | -- | 6.02 | -- | -- | -- |
Aptevo Therapeutics Inc | 0.00 | -27.31m | 2.25m | 40.00 | -- | 0.0322 | -- | -- | -98.49 | -97.90 | 0.00 | 9.06 | 0.00 | -- | -- | 0.00 | -103.85 | -47.16 | -134.86 | -85.03 | -- | -- | -- | -583.47 | -- | -- | 0.00 | -- | -100.00 | -- | -365.90 | -- | -- | -- |
Cyclacel Pharmaceuticals Inc | 449.00k | -19.85m | 2.36m | 12.00 | -- | -- | -- | 5.25 | -21.99 | -21.99 | 0.4636 | -1.67 | 0.0318 | -- | 0.1204 | -- | -139.57 | -57.58 | -314.22 | -69.81 | -- | -- | -4,386.86 | -18,789.29 | -- | -128.51 | -- | -- | -- | 22.87 | -6.34 | -- | -31.23 | -- |
Eloxx Pharmaceuticals Inc | 0.00 | -20.48m | 2.36m | 18.00 | -- | -- | -- | -- | -9.06 | -9.06 | 0.00 | -6.53 | 0.00 | -- | -- | 0.00 | -124.43 | -115.27 | -- | -155.33 | -- | -- | -- | -- | -- | -16.69 | -- | -- | -- | -- | 45.95 | -- | -22.56 | -- |
Data as of Jul 05 2024. Currency figures normalised to Galmed Pharmaceuticals Ltd's reporting currency: US Dollar USD
2.87%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Heights Capital Management, Inc.as of 31 Mar 2024 | 74.67k | 1.24% |
Walleye Capital LLCas of 31 Mar 2024 | 42.01k | 0.70% |
Two Sigma Advisers LPas of 31 Mar 2024 | 22.27k | 0.37% |
Two Sigma Securities LLCas of 31 Mar 2024 | 16.31k | 0.27% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 13.26k | 0.22% |
UBS Securities LLCas of 31 Mar 2024 | 2.26k | 0.04% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 1.24k | 0.02% |
Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 204.00 | 0.00% |
TSFG LLCas of 31 Mar 2024 | 200.00 | 0.00% |
Desjardins Securities, Inc.as of 31 Mar 2024 | 167.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.